• Publications
  • Influence
Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials.
*Department of Medical Oncology, Chafing Cross Hospital, Fulham Palace Road, London W6 8RF, U.K. t Cancer Research Campaign Experimental Cancer Chemotherapy Research Group, Cancer ResearchExpand
  • 650
  • 28
  • PDF
The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires
A self-report questionnaire module consisting of 24 items, comprising 5 scales and 7 single items, has been developed for measuring health-related quality of life in patients with brain cancer.Expand
  • 235
  • 22
Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856).
Temozolomide (CCRG 81045: M&B 39831: NSC 362856) is an analogue of mitozolomide displaying similar broad spectrum activity in mouse tumours, but showing considerably less myelosuppression in theExpand
  • 474
  • 18
  • PDF
EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients.
PURPOSE To evaluate the results of etoposide, methotrexate, and dactinomycin alternating with cyclophosphamide and vincristine (EMA/CO) chemotherapy in women with high-risk gestational trophoblasticExpand
  • 247
  • 15
Defining and measuring reproductive concerns of female cancer survivors.
Although women diagnosed with cancer during their childbearing years are at significant risk for infertility, we know little about the relationship between infertility and long-term quality of lifeExpand
  • 174
  • 12
259 patients with stage I non-seminomatous germ-cell testicular teratoma who were treated by orchidectomy alone and monitored at one often centres in the United Kingdom were followed for a median ofExpand
  • 354
  • 10
Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine
PURPOSE To evaluate the results of etoposide, cisplatin/etoposide, methotrexate, and actinomycin D (EP/EMA) chemotherapy in patients with gestational trophoblastic tumors (GTTs), who have relapsedExpand
  • 171
  • 8
Malignant ovarian germ cell tumors: identification of novel prognostic markers and long-term outcome after multimodality treatment.
PURPOSE Malignant ovarian germ cell tumors are rare and knowledge about prognostic parameters currently is limited. This study was undertaken to evaluate long-term outcome of patients with malignantExpand
  • 104
  • 8
Choriocarcinoma and partial hydatidiform moles
BACKGROUND Partial hydatidiform moles (PMs) rarely require chemotherapy and have never previously been proven to transform into choriocarcinoma, the most malignant form of gestational trophoblasticExpand
  • 281
  • 7
The use of significant others as proxy raters of the quality of life of patients with brain cancer.
OBJECTIVES The use of self-report questionnaires for the assessment of health-related quality of life (HRQOL) is increasingly common in clinical research. This method of data collection may be lessExpand
  • 198
  • 7